Ventures

Bilihome aims to revolutionize jaundice treatment for newborns by bringing safe and effective phototherapy from the hospital to the comfort of home. Currently, traditional methods require babies to be isolated in hospitals, disrupting bonding and caregiving between parents and infants. Bilihome's solution integrates blue light therapy into a comfortable garment, allowing newborns to receive treatment while being held, breastfed, and cared for as usual. This patient-centered innovation enables natural care at home, freeing up hospital bed space and promoting family-centric care.

Porous GmbH has developed an ultrasound technology that accurately diagnoses cortical bone health, addressing the limitations of traditional methods. Osteoporosis affects millions globally, leading to frequent and costly fractures. Current diagnostics often miss early-stage bone deterioration, but Porous GmbH’s patented algorithms allow ultrasound to measure bone quality at a microscopic level for a safer and more precise method for early detection of osteoporosis, also reducing healthcare costs.

The challenge with lung cancer lies in its late detection, often leading to unfortunate outcomes. Current screening methods like low-dose CT scans are costly and have radiation risks, while blood tests lack accuracy or are too expensive. Our solution offers a non-invasive blood test that detects lung cancer early with high sensitivity and specificity. This test, with its multi-protein panel, can identify even stage I cancer, improving survival rates and reducing unnecessary procedures.

Spinal cord Injury represents a large unmet medical need with approximately 1.2M new cases per year resulting mainly from motor vehicle accidents, falls and water related accidents. Currently available treatments only offer symptomatic relief but do not target the underlying pathophysiologic changes. The spinal cord injury market is predicted to reach US$3B by 2025. MLP-1236 is a First in class dual inhibitor of matrix metalloproteinases (MMP) 9 and MMP 12 and has already completed Phase 1 and Phase 2a clinical studies. In preclinical models, MLP-1236 was effective in preventing/reversing the neurodegeneration associated with spinal cord injury and ischemic stroke.

Timelab addresses the challenge of ambulance delays in the Netherlands by offering a proactive solution through their Emergency Mathematics software. With 7% of ambulance arrivals exceeding the 15-minute target, 35,000 patients annually don't receive timely care, impacting mortality and morbidity rates. Timelab's software predicts future demand and facilitates the proactive relocation of ambulances, aiming to reach 95% of high emergency call locations within 15 minutes, compared to the current 93%.

Introducing Liftya, a solution for shoulder instability. Developed with a patented spherical hinge mechanism, Liftya mimics the natural shoulder joint movement, offering stability and full range of motion. Unlike traditional braces, Liftya promotes motor recovery and independence, reducing pain and healthcare costs for patients.

Polynerve is a cutting-edge solution for repairing nerve injuries, offering a better alternative to traditional methods like autografting. Its unique design helps nerves grow in the right direction, reducing complications and surgical time. This absorbable option improves patient recovery and simplifies surgery for healthcare providers, making it a game-changer in nerve repair procedures.

Flash Pathology revolutionizes tissue assessment with its scanner, with immediate imaging of biopsy and surgical specimens in the moment of operation. Unlike traditional methods, taking hours and requiring extensive labor, the Flash Pathology scanner visualizes cell structures within seconds without any preparation. This, non-labor-intensive solution enables distinguishing healthy tissue from tumors in real-time, reducing the need for revision surgeries and unnecessary biopsies.